T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Patterson-UTI
PTEN
$4.2B
| $20.6M | ﹤0.01% |
1,564,437
+105,090
| +7% | +$1.67M |
|
1077
Mohawk Industries
MHK
$9.27B
| $20.5M | ﹤0.01% |
112,581
+1,400
| +1% | +$277K |
|
1078
Hudbay
HBM
$11.8B
| $20.3M | ﹤0.01% |
5,527,030
+1,415,200
| +34% | +$8.14M |
|
1079
Constellium
CSTM
$3.95B
| $20.3M | ﹤0.01% |
3,342,611
+560,340
| +20% | +$4.67M |
|
|
KYNB
1080
Kyntra Bio
KYNB
$28.7M
| $20.3M | ﹤0.01% |
36,953
-408
| -1% | -$247K |
|
|
SINA
1081
DELISTED
Sina Corp
SINA
| $20.2M | ﹤0.01% |
+504,684
| New | +$20.4M |
|
1082
Kosmos Energy
KOS
$1.51B
| $20.2M | ﹤0.01% |
3,621,028
+1,511,509
| +72% | +$10.5M |
|
|
ATW
1083
DELISTED
Atwood Oceanics
ATW
| $20.2M | ﹤0.01% |
1,362,710
-65,210
| -5% | -$1.27M |
|
|
AMAG
1084
DELISTED
AMAG Pharmaceuticals
AMAG
| $20.2M | ﹤0.01% |
507,560
+43,090
| +9% | +$2.67M |
|
|
AWAY
1085
DELISTED
HOMEAWAY INC COM
AWAY
| $20.2M | ﹤0.01% |
759,620
+1,500
| +0.2% | +$44.1K |
|
1086
The Ensign Group
ENSG
$10.6B
| $20.1M | ﹤0.01% |
1,005,871
-63,071
| -6% | -$1.45M |
|
|
GNMK
1087
DELISTED
GenMark Diagnostics, Inc
GNMK
| $19.9M | ﹤0.01% |
2,534,354
-30,200
| -1% | -$279K |
|
1088
U-Haul Holding Co
UHAL
$14.5B
| $19.9M | ﹤0.01% |
505,000
-42,000
| -8% | -$1.53M |
|
|
HMSY
1089
DELISTED
HMS Holdings Corp.
HMSY
| $19.8M | ﹤0.01% |
2,259,758
+1,980
| +0.1% | +$22.1K |
|
|
HPY
1090
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
| $19.8M | ﹤0.01% |
314,235
+6,400
| +2% | +$381K |
|
1091
Crocs
CROX
$6.26B
| $19.8M | ﹤0.01% |
1,530,250
-162,870
| -10% | -$2.36M |
|
1092
Robert Half
RHI
$4.25B
| $19.7M | ﹤0.01% |
385,153
-5,400
| -1% | -$291K |
|
|
RLYP
1093
DELISTED
RELYPSA INC COM
RLYP
| $19.7M | ﹤0.01% |
1,062,559
-663,080
| -38% | -$18.2M |
|
|
LDL
1094
DELISTED
Lydall, Inc.
LDL
| $19.7M | ﹤0.01% |
689,810
+2,600
| +0.4% | +$74.3K |
|
1095
Houlihan Lokey
HLI
$9.24B
| $19.6M | ﹤0.01% |
+899,280
| New | +$19.7M |
|
1096
Labcorp
LH
$26.2B
| $19.5M | ﹤0.01% |
209,766
-5,390
| -3% | -$558K |
|
|
MRC
1097
DELISTED
MRC Global
MRC
| $19.5M | ﹤0.01% |
1,749,800
+1,720,700
| +5,913% | +$22.5M |
|
1098
Agnico Eagle Mines
AEM
$93.8B
| $19.5M | ﹤0.01% |
772,890
+7,100
| +0.9% | +$173K |
|
1099
Ameren
AEE
$30.1B
| $19.3M | ﹤0.01% |
456,414
-2,200
| -0.5% | -$88.6K |
|
1100
Realty Income
O
$59.6B
| $19.3M | ﹤0.01% |
419,394
+18,070
| +5% | +$816K |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.